Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Human Interleukin-2 for Injection

Approval Number

国药准字S10980069

Company北京远策药业有限责任公司

Registration Date

July 15, 2020

Drug Information

Generic Name

注射用人白介素-2

Trade Name

远策欣

Dosage Form

注射剂(冻干)

Strength

100万IU/支

Drug Type

生物制品

Registration Date

July 15, 2020

Company Information

Applicant Company

Company Name北京远策药业有限责任公司

Manufacturing Company

Company Name北京远策药业有限责任公司

Company Address

（生产地址）北京市北京经济技术开发区荣昌东街7号隆盛工业园9号厂房

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy